Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis
- PMID: 30407100
- DOI: 10.1089/jwh.2018.7319
Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis
Abstract
Background: Persistent pulmonary hypertension of the newborn (PPHN) is a serious condition associated with substantial mortality and morbidity. Previous studies have suggested a possible link between maternal selective serotonin reuptake inhibitor (SSRI) use and the risk of PPHN. This study aimed to provide an up-to-date review and meta-analysis of the topic.
Methods: Using the search terms [SSRI OR SSRIs OR selective serotonin reuptake inhibitors OR antidepressant OR Prozac OR fluoxetine OR Lexapro OR escitalopram] AND [pregnancy OR maternal OR newborn OR persistent pulmonary hypertension OR PPHN OR neonat* OR fet*], a preliminary search on the PubMed, Medline, EMBASE, Web of Science, and Google Scholar database yielded 7327 articles published in English between January 1, 1960 and October 1, 2017.
Results: A total of 9 cohort and case-control studies, with a total of 7,540,265 subjects were systematically reviewed. Random-effects meta-analysis of eight studies revealed a significantly increased risk of PPHN with maternal SSRI use during pregnancy, with a pooled OR of 1.516 (95% confidence interval: 1.035-1.997, p < 0.001). Overall, the absolute increase in risk of PPHN with SSRI use appears small, with an absolute risk difference of 0.619 per 1000 livebirths and a number needed to harm of 1615 women.
Conclusions: Current evidence suggests that there were significantly greater odds of PPHN with SSRI use during pregnancy. However, the clinical significance of this association remains modest and likely outweighed by the potential benefits of treatment of perinatal depression. The risk of PPHN associated with SSRI therapy might not warrant the recommendation to withdraw antidepressant therapy, as evidence from other studies show that untreated perinatal depression presents additional adverse maternal and fetal outcomes. Given the increasing prevalence of maternal depression and consequent use of antidepressant medications, further research with robust longitudinal or randomized, controlled studies and mechanistic investigations are needed.
Keywords: PPHN; SSRI; antenatal; antidepressant; pregnancy; pulmonary hypertension of the newborn.
Similar articles
-
Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.JAMA. 2015 Jun 2;313(21):2142-51. doi: 10.1001/jama.2015.5605. JAMA. 2015. PMID: 26034955 Free PMC article.
-
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.N Engl J Med. 2006 Feb 9;354(6):579-87. doi: 10.1056/NEJMoa052744. N Engl J Med. 2006. PMID: 16467545
-
SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.Br J Clin Pharmacol. 2017 May;83(5):1126-1133. doi: 10.1111/bcp.13194. Epub 2017 Jan 18. Br J Clin Pharmacol. 2017. PMID: 27874994 Free PMC article.
-
Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.Am J Psychiatry. 2012 Feb;169(2):134-40. doi: 10.1176/appi.ajp.2011.11040553. Am J Psychiatry. 2012. PMID: 22420034 Review.
-
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.BMJ. 2014 Jan 14;348:f6932. doi: 10.1136/bmj.f6932. BMJ. 2014. PMID: 24429387 Free PMC article. Review.
Cited by
-
A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension.Biomedicines. 2023 Nov 14;11(11):3049. doi: 10.3390/biomedicines11113049. Biomedicines. 2023. PMID: 38002049 Free PMC article. Review.
-
[Effects of calcium-sensitive receptors on 11β-hydroxysteroid dehydrogenase type 2 and cortisol in neonatal mice with persistent pulmonary hypertension].Zhongguo Dang Dai Er Ke Za Zhi. 2019 Nov;21(11):1124-1130. doi: 10.7499/j.issn.1008-8830.2019.11.013. Zhongguo Dang Dai Er Ke Za Zhi. 2019. PMID: 31753096 Free PMC article. Chinese.
-
Pharmacological treatment of bipolar disorder in pregnancy: An update on safety considerations.Indian J Pharmacol. 2022 Nov-Dec;54(6):443-451. doi: 10.4103/ijp.ijp_407_21. Indian J Pharmacol. 2022. PMID: 36722556 Free PMC article. Review.
-
Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease.Int J Mol Sci. 2023 Mar 1;24(5):4765. doi: 10.3390/ijms24054765. Int J Mol Sci. 2023. PMID: 36902195 Free PMC article. Review.
-
Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child.Curr Psychiatry Rep. 2022 Nov;24(11):687-695. doi: 10.1007/s11920-022-01372-x. Epub 2022 Oct 1. Curr Psychiatry Rep. 2022. PMID: 36181572 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical